Sopharma AD (BUL:SFA)
5.80
0.00 (0.00%)
At close: Feb 26, 2025
Sopharma AD Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Operating Revenue | 2,121 | 1,874 | 1,663 | 1,603 | 1,439 | Upgrade
|
Other Revenue | 24.2 | 13.53 | 8.5 | 8.04 | 7.31 | Upgrade
|
Revenue | 2,145 | 1,888 | 1,672 | 1,611 | 1,446 | Upgrade
|
Revenue Growth (YoY) | 13.62% | 12.95% | 3.73% | 11.42% | 12.27% | Upgrade
|
Cost of Revenue | 1,668 | 1,472 | 1,306 | 1,264 | 1,131 | Upgrade
|
Gross Profit | 476.82 | 415.51 | 365.37 | 346.96 | 315.22 | Upgrade
|
Selling, General & Admin | 319.88 | 255.31 | 215.55 | 221.99 | 213.25 | Upgrade
|
Other Operating Expenses | 16.4 | 11.69 | 11.76 | 7.3 | 11.84 | Upgrade
|
Operating Expenses | 397.72 | 322.92 | 279.51 | 285.48 | 271.87 | Upgrade
|
Operating Income | 79.1 | 92.59 | 85.86 | 61.48 | 43.35 | Upgrade
|
Interest Expense | -16.65 | -10.98 | -6.02 | -10.79 | -12.41 | Upgrade
|
Interest & Investment Income | - | 4.37 | 3.19 | 4.87 | 5.23 | Upgrade
|
Earnings From Equity Investments | 25.72 | 24.74 | 22.64 | 12.09 | 5.98 | Upgrade
|
Currency Exchange Gain (Loss) | - | -1.31 | -0.13 | 2.29 | -7.41 | Upgrade
|
Other Non Operating Income (Expenses) | 3.12 | -2.63 | -3.19 | -0.94 | -0.76 | Upgrade
|
EBT Excluding Unusual Items | 91.29 | 106.78 | 102.35 | 69 | 33.98 | Upgrade
|
Impairment of Goodwill | - | - | -9.6 | - | -3.5 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | -1.59 | 0.15 | 0.09 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.17 | 4.69 | 1.95 | 38.01 | 0.41 | Upgrade
|
Asset Writedown | - | -1.44 | -8.46 | -10.34 | -2.32 | Upgrade
|
Legal Settlements | - | - | - | - | 0.17 | Upgrade
|
Other Unusual Items | - | 0.87 | 0.43 | 0.75 | 2.61 | Upgrade
|
Pretax Income | 91.46 | 110.9 | 85.08 | 97.57 | 31.44 | Upgrade
|
Income Tax Expense | 9.07 | 11.82 | 8.74 | 5.87 | 6.16 | Upgrade
|
Earnings From Continuing Operations | 82.4 | 99.08 | 76.33 | 91.7 | 25.28 | Upgrade
|
Minority Interest in Earnings | -4.55 | -3.87 | -5.21 | -2.21 | 4.53 | Upgrade
|
Net Income | 77.85 | 95.21 | 71.12 | 89.5 | 29.81 | Upgrade
|
Net Income to Common | 77.85 | 95.21 | 71.12 | 89.5 | 29.81 | Upgrade
|
Net Income Growth | -18.24% | 33.87% | -20.53% | 200.27% | -65.74% | Upgrade
|
Shares Outstanding (Basic) | 166 | 131 | 121 | 125 | 126 | Upgrade
|
Shares Outstanding (Diluted) | 166 | 140 | 125 | 125 | 126 | Upgrade
|
Shares Change (YoY) | 18.14% | 12.23% | -0.36% | -0.31% | -0.11% | Upgrade
|
EPS (Basic) | 0.47 | 0.73 | 0.59 | 0.71 | 0.24 | Upgrade
|
EPS (Diluted) | 0.47 | 0.68 | 0.57 | 0.71 | 0.24 | Upgrade
|
EPS Growth | -30.88% | 19.30% | -19.72% | 199.57% | -65.70% | Upgrade
|
Free Cash Flow | 43.25 | 20.64 | 90.74 | -96.31 | -202.96 | Upgrade
|
Free Cash Flow Per Share | 0.26 | 0.15 | 0.73 | -0.77 | -1.61 | Upgrade
|
Dividend Per Share | - | 0.990 | 0.600 | - | - | Upgrade
|
Dividend Growth | - | 65.00% | - | - | - | Upgrade
|
Gross Margin | 22.23% | 22.01% | 21.86% | 21.53% | 21.80% | Upgrade
|
Operating Margin | 3.69% | 4.90% | 5.14% | 3.82% | 3.00% | Upgrade
|
Profit Margin | 3.63% | 5.04% | 4.25% | 5.55% | 2.06% | Upgrade
|
Free Cash Flow Margin | 2.02% | 1.09% | 5.43% | -5.98% | -14.03% | Upgrade
|
EBITDA | 140.54 | 127.15 | 118.97 | 93.85 | 74.19 | Upgrade
|
EBITDA Margin | 6.55% | 6.73% | 7.12% | 5.82% | 5.13% | Upgrade
|
D&A For EBITDA | 61.45 | 34.56 | 33.11 | 32.37 | 30.84 | Upgrade
|
EBIT | 79.1 | 92.59 | 85.86 | 61.48 | 43.35 | Upgrade
|
EBIT Margin | 3.69% | 4.90% | 5.14% | 3.82% | 3.00% | Upgrade
|
Effective Tax Rate | 9.91% | 10.66% | 10.28% | 6.02% | 19.60% | Upgrade
|
Advertising Expenses | - | 36.96 | 22.06 | 27.41 | 28.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.